DISCOVERY LIMITED - Annual Results for the year ended 30 June 2026 and Cash Dividend Declaration
What this filing means
Discovery's FY2026 results met the guidance ranges set eight days earlier. Normalised operating profit rose 17% to R17.75 billion and normalised HEPS grew 20%, landing inside their bands of 15–20% and 18–23% respectively. Basic EPS of 1,936.7 cents and HEPS of 1,925.6 cents also met their narrower per-share ranges. The headline 34% HEPS growth and 38% EPS growth are inflated by the 1 Discovery Place lease termination gain and the CMT partial sale. The -4.7% share drift into the print is notable: some de-risking had occurred ahead of the announcement, which means the results landing cleanly within guidance may carry slightly more constructive weight than a flat drift would suggest, though guidance absorption limits the upside surprise available.
Discovery made more money than last year and is paying a bigger dividend. But the company had told the market roughly what to expect a week earlier, and the results landed inside those ranges. The most impressive-looking numbers were boosted by one-off items, and the share had drifted down slightly before the announcement — suggesting some investors had already reduced their positions, which gives the in-line results a modest constructive lean rather than being a neutral non-event.
Bull case
- Discovery SA increased normalised operating profit 16% to R13 868 million while new-business API rose 8% to R19 534 million.
- Vitality increased normalised operating profit 21% to R3 882 million.
- Cash conversion improved 5 percentage points to 85% from 80%.
- Normalised profit from operations grew 17% to R17 750 million from R15 210 million.
- The financial leverage ratio fell 1.4 percentage points to 15.4% from 16.8%.
Bear case
- Basic EPS growth of 38% and HEPS growth of 33% were flattered by the 1 Discovery Place lease termination gain and the CMT partial sale; normalised HEPS growth of 20% met but did not exceed the guided range.
- Return on embedded value declined 1.6pp to 14.1%, a metric to watch as EV growth and capital returns interact with interest rate and foreign exchange effects.
- No FY2027 forward guidance is provided, leaving the trajectory of normalised growth, embedded value and deleveraging uncertain.
- The filing does not separately quantify the CMT partial sale proceeds versus the 1 Discovery Place lease termination gain within the total headline-normalised reconciliation, though both drivers are named.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
Results that meet, rather than beat, the bar Discovery set eight days earlier. The 17% normalised operating profit growth, 85% cash conversion, and reduced leverage are substantive quality signals, and the -4.7% pre-announcement drift indicates some de-risking into the print — meaning the confirmation landing cleanly may carry slightly more constructive weight than it would on a flat or positive drift. However, with guidance fully absorbed and no FY2027 outlook given, the room for a fresh re-rating is limited. So what: the operating engine is performing as guided, but the market still needs FY2027 guidance to assess whether mid-teen normalised growth is the floor or the ceiling.
The next trading statement or results presentation is where the market will test whether normalised growth can hold at mid-teens without the one-off gains, and whether the de-risking seen ahead of this print was warranted or excessive.
Evidence from the filing
Basic EPS growth of 38% and HEPS growth of 33% were flattered by the 1 Discovery Place lease termination gain and the CMT partial sale; normalised HEPS growth of 20% met but did not exceed the guided range.
“Headline earnings increased by 34%, boosted by the gains realised through the early termination of the long-term lease following the acquisition of 1 Discovery Place, the Group's head office. The partial sale of the Group's stake in Cambridge Mobile Telematics (CMT) resulted in a further increase in basic earnings, which increased 39%.”
Return on embedded value declined 1.6pp to 14.1%, a metric to watch as EV growth and capital returns interact with interest rate and foreign exchange effects.
“Annualised return on opening embedded value (RoEV) % 14.1 15.7 (1.6)pp”
Discovery SA increased normalised operating profit 16% to R13 868 million while new-business API rose 8% to R19 534 million.
“Discovery SA increased normalised operating profit by 16% to R13 868 million”
Vitality increased normalised operating profit 21% to R3 882 million.
“Vitality normalised operating profit of R3 882 million increased by 21%”
Cash conversion improved 5 percentage points to 85% from 80%.
“Cash conversion(1) % 85 (June 2025: 80) change 5pp”
Normalised profit from operations grew 17% to R17 750 million from R15 210 million.
“normalised profit from operations R million 17 750 (June 2025: 15 210) change 17%”
The financial leverage ratio fell 1.4 percentage points to 15.4% from 16.8%.
“Financial leverage ratio (FLR) % 15.4 (June 2025: 16.8) change 1.4pp”
More on Discovery Limited
Related filings
More from DSY
- DISCOVERY LIMITED - Final Preference Share Cash Dividend Declaration
- DISCOVERY LIMITED - Trading statement for the year ended 30 June 2026
- DISCOVERY LIMITED - Dealings in Securities by a Director
- DISCOVERY LIMITED - Disclosure of Beneficial Interest in Securities
- DISCOVERY LIMITED - Voluntary Announcement - Partial Disposal of Interest in Cambridge Mobile Telematics Incorporated
Other Results
- AIRPORTS COMPANY SOUTH AFRICA SOC LIMITED - Invitation to the Release of the Annual Financial Results
- FFBFORTRESS REAL ESTATE INVESTMENTS LIMITED - Consolidated audited financial results for the year ended 30 June 2026 and prospects
- IMPIMPALA PLATINUM HOLDINGS LIMITED - Audited Consolidated Annual Results for the financial year ended 30 June 2026 and Cash Dividend Declaration
- SNTSANTAM LIMITED - Unaudited Condensed Consolidated Interim Financial Statements for the six months ended 30 June 2026 and Declaration of Ordinary Dividend
- APNASPEN PHARMACARE HOLDINGS LIMITED - Reviewed Condensed Group Financial Results for the year ended 30 June 2026 and Cash Dividend Declaration